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In January 2010, the state
challenged the University of
Tennessee to become a Top
25 public research university
in a decade*, and the UT
Graduate School of Medicine
accepted this challenge,
knowing that the journey will
be as important as the end
result. The improvements will
• Increase the quality and
value of education
• Further develop our
strengths in research
• Expand our contribution to economic growth and
development
• Strengthen the University of Tennessee’s flagship
campus for the benefit of all Tennesseans.
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In this issue of Advance, you will read about many
exciting research endeavors by our faculty, residents,
fellows and students. These efforts exemplify our
commitment to improving our knowledge of diseases
and how that knowledge can be applied to improve
patient care and outcomes. In responding to the call
to become a Top 25 public research institution, our
challenge is to build upon our recognized strengths
by expanding the existing expertise and infrastructure
dedicated to outcomes-driven basic and clinical/applied
research.
To that end, the Graduate School of Medicine
must foster external collaborations not only with UT
Knoxville but also with local industry and government
and academic institutions outside of Tennessee. One
such collaboration is the comparative research between
the Graduate School of Medicine and UT College of
Veterinary Medicine.
Advances in human and veterinary medicine are
dependent on an overlapping collection of technologies
and research discoveries. Healthy interactions between
the Graduate School of Medicine and College of
Veterinary Medicine already have benefitted both
animal and human health. Our recent work with a
radio-labeled fatty acid for myocardial PET/CT imaging
in healthy cats can be directly applied to pet cats and
humans with heart disease and diabetes. Another recent
study of how the brains of healthy dogs utilize glucose
will support future studies in animals and humans
suffering from inflammatory brain diseases. These are
examples of how collaboration can bring new insight to
our research programs and better healthcare to patients
of all walks of life.
This collaborative approach to research allows us
to deepen and broaden our ongoing efforts to achieve
the cutting edge of science and biomedical research,
ultimately enhancing how we perform our daily tasks in
research, teaching, service and patient care.
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Oscar Grandas:

He knew he wanted to be a specialist and that the social circumstances in Colombia would not allow him to achieve this, so
Colombian-born Oscar Grandas, M.D., turned his gaze toward America. Grandas also heads the Vascular Research Laboratory
to help women with vascular disease.

Medicine. His work there started many years ago
To say Oscar Grandas is resolute is nothing
when he observed in some of his patients that
new to him. He says it, himself. Born and
hormone replacement therapy seemed to adversely
raised in Bogota, Colombia, Grandas states that
affect bypass grafts and stent patency. He has
Colombians are very entrepreneurial by nature,
spent years investigating this observation and is
and in his career, Grandas has competed and
making a difference in the lives of many patients.
excelled, using his inherent drive to his advantage
Getting to this point in his career, however, was
and to the benefit of his patients. But there’s more
not particularly easy. During his years in medical
to this successful doctor and researcher.
school at Universidad Nacional De Colombia,
The outpaced spirit of Grandas does not
political turmoil, social instability, drug trafficking
manifest in brashness. It’s not showy or loud. He
and violence were
doesn’t seek the spotlight
I came here with two ideas:
invading his homeland.
and in fact is quick to
Look into hormone replacement
“One night while I
turn it onto others.
was on duty, a bomb
Grandas is humble.
therapy and investigate
exploded near the
What he achieves in
metalloproteinases….Both
hospital,” Grandas
the operating room and
studies can lead to improved
recalls. “We cared for
research lab is not only
outcomes
for
women
with
the victims of the attack
done with the constant
throughout the night.”
hum of the determination
vascular disease.
Nearing the end of
to excel but also with a
-Oscar Grandas, M.D.
medical school, Grandas
spirit of partnership and
knew he wanted to be a surgeon, “but there
gratification, which he uses to help his patients.
were a very limited number of surgical residency
Oscar H. Grandas, M.D., serves in many roles.
positions in the country,” he explains. He knew
He is an associate professor in the Department
he had to leave.
of Surgery, Division of Vascular/Transplant
His desire to become a specialist coupled with
Surgery, and the director of the Transplant Center
his country’s instability “made leaving easier,” he
and Vascular Access Center at the University of
says. He accepted a surgical residency position
Tennessee Medical Center. He also serves as
at Washington Hospital Center in Washington,
the medical director of the Vascular Research
D.C., and upon completion of the first two
Laboratory at the UT Graduate School of
2

Surgeon and Researcher Investigates HRT
Grandas knew where he wanted
to settle down and continue
practicing medicine and
conducting research: UT Graduate
School of Medicine.
“Dr. [Mitch] Goldman has
been a tremendous influence on
my career,” Grandas says of the
assistant dean for Research and
chair of the Department of Surgery.
“I knew he would support research
the way I wanted to do it. I needed
to develop as a surgical scientist,
and the opportunity was here.”
Plus, the research in vascular
interventions he had conducted
during the vascular surgery
fellowship had remained in his
mind, and he wanted to come back
to see where it could lead.
“I came here with two
ideas: Look into hormone
replacement therapy and
investigate metalloproteinases,” Grandas says.
“I wanted to partner with people who bring
scientific knowledge to research and would help
us consider what we can do with our ideas.”
Grandas partnered with Deidra Mountain,
Ph.D., who now is the scientific director of
the Vascular Research Laboratory, a basic and
translational research facility at the Graduate
School of Medicine. Together, they are
investigating the role of hormone replacement
therapy (HRT) in post-menopausal women
who have undergone vascular interventions that
have failed. Grandas also is looking at intimal
hyperplasia, a thickening of the vascular walls,
in women taking HRT. Both studies can lead
to improved outcomes for women with vascular
disease.
Grandas also mentors Ph.D. students and
collaborates with organizations such as the
Computational Sciences and Engineering
Division of Oak Ridge National Laboratory
and various departments at the University of
Tennessee, Knoxville.
“I like to feel I’m contributing to discovery,”
Grandas says. “I have gratification every day
through my transplant and vascular surgery
patients, and research is fulfilling, because it adds a
different dimension to my career.”

years as a preliminary
surgical resident, he came
to the Graduate School of
Medicine to complete his
general surgery residency.
Still not enough for this
driven doctor, he returned
to D.C. for a fellowship in
transplantation, then came
back to the Graduate School
of Medicine for yet another
vascular surgery fellowship.
It was during his first stint
in Washington that Oscar
Grandas was first introduced
to research.
“In Colombia, we greatly
admire researchers,” he
says, “but there are not
many resources available
to conduct basic science
research in the country.”
In his general surgery
residency in D.C., the chair of the department
asked him to assist with shock research, and
Grandas learned the value of basic science
research. Later, as part of his vascular surgery
fellowship at the Graduate School of Medicine,
he was involved with several vascular biology
research projects—research that would later play
a major role in directing his career.
Once he completed his residencies and
fellowships, Grandas, as a foreign national, was
required to serve at a federally funded medical
institution, so he worked at the Veterans
Administration Hospital affiliated with the Medical
College of Georgia. He served as a transplant
surgeon and conducted research to discover more
about immunology and tolerance in transplants.
“Research mentorship at the Institute of
Molecular Immunology and Genetics was
outstanding. Researchers taught me the tools of
basic science research, and I’m very grateful to them
for that,” Grandas says.
Two years later, Grandas had his own lab at
the Veterans Administration Hospital. “I was
researching dendritic cells found in early pregnancy
and how they could help suppress the immune
system and create tolerance in transplant patients,”
he explains.
When his time in Georgia was complete,
3

Helping Surgery

Researching the Connection between Bariatric S

Matthew Mancini, M.D., Hollie Raynor, Ph.D., Greg Mancini, M.D., are collaborating on research to help patients who
undergo bariatric surgery succeed.

More than one-third of American adults are
obese.* Some people turn to bariatric surgery
to help them lose weight and reclaim a higher
quality of life, and new research examining food
cravings led by two surgeons and a dietitian
nutritionist is helping ensure their success.
Recently, Matthew Mancini, M.D., and
Greg Mancini, M.D., associate professors in the
Department of Surgery and co-directors of the
Tennessee Weight Loss and Surgery Center at the
University of Tennessee Medical Center, teamed
with Hollie Raynor, Ph.D., R.D., L.D.N., an
associate professor in the UT Department of
Nutrition, to conduct a study to understand
the psychology and biology of weight loss after
bariatric surgery. The Mancinis are highly

skilled at performing the three types of bariatric
(weight loss) surgery available today: Gastric
bypass, laparoscopic adjustable gastric banding
(lap band) and vertical sleeve gastrectomy. They
realize, however, that a successful surgery does
not always translate to weight loss.
“After surgery, if patients regain weight or don’t
lose weight, we consider it a failure,” Greg Mancini
says. “Our goal is to help our patients eliminate
those failures, and that is why we are investigating
ways beyond surgery to help them succeed.”
Losing weight after surgery requires drastic
lifestyle changes, so the team’s research is
examining cravings and other changes that might
be important for understanding the effects of
surgery on weight loss.

Why this matters:

Obesity robs people of health and quality of life.
Understanding cravings and other biological and
psychological changes after bariatric surgery can
help people succeed with weight loss and reclaim
quality of life.
4

Succeed:

Surgery and Cravings

Also of interest is
understanding the biological
changes in the body after
surgery. The stomach and
intestines produce hormones
that affect behavior, including
sensory taste experience. When
the gut is surgically altered, the
hormones that are produced also
are changed, sometimes resulting
in unexpected cravings and
behaviors.
The research, which started
in June 2011, will follow 90
patients from pre-surgery
through the first year after
surgery. The team believes
The laparoscopic adjustable banding (lap band) is one option for bariatric surgery.
preliminary findings will be
submitted this spring.
“We believe food cravings after weight loss
“Results
of
the
study should have significant
surgery can shift dramatically and differently
clinical implications for postoperative dietary
depending on the type of surgery a patient
recommendations,
undergoes,” says
which often are
The team’s research is
Raynor. “We
vague and difficult
are analyzing
examining cravings and
for patients to
patients’ selection
other
changes
that
understand and
and variety of
follow,” Raynor says.
might be important for
foods consumed
physicians and
and trying to
understanding the effects When
patients
understand
connect those
to food cravings of surgery on weight loss. and anticipate
changes in dietary
and changes in
variety and food cravings in relation to weight
weight after surgery.”
loss surgery, they can better manage dietary
Cravings before and after bariatric surgery can
adherence.
cause unhealthy eating patterns and undermine the
“The more information we have about why
effects of surgery. Similarly, greater dietary variety
surgeries do or do not work for our patients, the
can contribute to disruption of satiation processes
better we can help them,” Matthew Mancini says.
and cause overconsumption. The team’s research
“It doesn’t stop at the operating room door.”
is investigating whether weight loss surgery
Source: Centers for Disease Control and Prevention

influences changes in dietary variety and cravings
and how the changes can predict weight loss.
5

Sudden Cardiac Death an

Irfan Asif, M.D., is leading a study of sudden cardiac death in athletes.

understand
potential
mechanisms for
cardiac arrest in
distance athletes.”
Along with this
causal research, Asif is
establishing better protocols for
screening athletes. Currently, the
recommended protocol is limited to a
history and physical exam.
“Studies show that the traditional method
of screening is less than 33 percent effective in
detecting occult cardiac disease in athletes,” says
Asif. “Up to 80 percent of athletes who suffer
cardiac arrest are asymptomatic with no warning
signs of disease.”
Asif believes that adding an electrocardiogram
(ECG)—a non-invasive test that shows electrical
activity in the heart—to pre-participation athletic
screening will identify many of the diseases
associated with SCD. He is collaborating with
Xiaopeng Zhao, Ph.D., an assistant professor
in the UT College of Engineering, Mechanical,
Aerospace and Biomedical Engineering, to
improve ECG signal quality and design an
algorithm for interpreting the ECG. This
algorithm will immediately indicate if the

Sudden cardiac death (SCD) is the leading
cause of death of young athletes. It is caused
by occult cardiovascular abnormalities that are
exacerbated during vigorous exercise.
The paradoxical death of an apparently
healthy young athlete understandably raises
scrutiny regarding prevention strategies, so Irfan
M. Asif, M.D., director of the Sports Medicine
Program and an assistant professor in Family
Medicine, is aggressively investigating SCD. His
recent groundbreaking study with the National
Collegiate Athletic Association (NCAA) was the
first to report the rate of SCD in college athletes
(1 in 40,000). More alarming was the rate of
SCD in high-risk populations, such as NCAA
male Division I basketball players, whose rate of
SCD was found to be 1 in 3,000.
One part of his research focuses on defining
the epidemiology of SCD, and results of a unique
collaboration with Sophy Jesty, D.V.M., an
assistant professor at the UT College of Veterinary
Medicine, will help.
“We are trying to determine if vigorous exercise
in endurance athletes, such as marathoners, can
lead to subtle scar formation in the heart,” Asif
explains. The team is testing cardiovascular
activity during endurance exercise in a canine
model. “Results would be some of the first to
6

nd the Role of Research
Energy Drinks
and Athletes

equipment is being used incorrectly.
“We are hoping to build a fail-safe
mechanism to help make sure the ECG
gives the athlete and doctor correct
information,” Asif says.
Beyond the clinical process
of pre-participation screenings,
Asif is working with
Jeffrey Fairbrother, Ph.D.,
Leslee Fisher, Ph.D., and
Rebecca Zakrajsek, Ph.D.,
in the UT Department of
Kinesiology, Recreation and
Sports Studies, to determine the
psychological impact on athletes who
have screenings that include ECG.
These athletes currently report that
if screened they feel safer and more
confident while playing sports.
Despite the best efforts of
screening, however, cases of cardiac
arrest in athletes could occur. Thus,
Asif also is advocating for more
automatic external defibrillators (AED)
and coordinated emergency action plans at
sporting venues.
His research is making an impact in
the world of sports. He recently presented
his findings and recommendations as the
U.S. representative at a meeting of the Spanish
Olympic Committee, and his work has won
numerous national awards:
• American Medical Society for Sports Medicine
(AMSSM) Best Overall Research Award (2010)
• AMSSM Harry Galanty Most Outstanding
Young Investigator Award (2011, 2012)
• Society of Teachers of Family Medicine Best
Overall Research Paper (2012).
But more importantly, Dr. Asif’s work can save
the lives of athletes.

Energy drinks and questions about their
potential dangers recently have made
headlines. Irfan M. Asif, M.D., who is
leading a comprehensive study on sudden
cardiac death in athletes believes energy
drinks consumed in excess can, indeed,
be harmful.
“Energy drinks alter the perceived level
of exertion and lengthen the time to
exhaustion,” Asif says.

He believes stimulants and other substances
in the drinks can trigger an arrhythmia if
used in excess, particularly if the consumer
has an unknown abnormality of the heart.
“For people who are physically active,
overly consuming energy drinks could
exacerbate an occult abnormality to a
more noticeable degree,” he says.
For more information, speak with your
sports medicine or primary care physician.

Why this matters:

This year, more than 150 young athletes will die while
engaging in activities that are otherwise healthy.
Understanding the causes of Sudden Cardiac Death,
improving the pre-participation screening protocol for
athletes and being prepared with an emergency plan
that utilizes an AED will save lives.
7

Clinical Trials:
Therapeutic and Diagnostic
Clinical trials typically provide
therapeutic solutions. At the UT
Graduate School of Medicine, for
example, clinical trials have helped
bring new treatments to cancer
patients, including Avastin® and
tamoxifen; new imaging technology
for patients with amyloid disease; and
improved vascular grafts for trauma
patients.
Clinical trials also can be diagnostic
investigations or translational research
studies. These trials seek to determine
causes, so treatment decisions can
be made more accurately. Eric R.
Carlson, D.M.D., M.D., Department
of Oral and Maxillofacial Surgery,
is leading a diagnostic study to
determine the value of positron
emission tomography/computed
tomography (PET/CT) scans.
The study involves imaging lymph nodes of the
neck in patients with oral/head and neck cancer
using two tracers, FLT and FDG. If PET/CT
can accurately predict the presence or absence
of metastatic cancer within the nodes, surgeons
can provide more precise surgery. For more
information, contact the Department of Oral and
Maxillofacial Surgery at 865-305-9022.
Craig Towers, M.D., Maternal Fetal Medicine,
is leading a clinical trial to study the accuracy
of the lamellar body count in amniotic fluid
contaminated by meconium, a newborn’s
first stool. The lamellar body count is a wellestablished test for fetal lung maturity, but little
research has been conducted on its accuracy when

amniotic fluid contains meconium. Participants
are women with high-risk pregnancies who
are undergoing amniocenteses and consent
to involvement. This study is enrolling. For
information, contact the Department of
Obstetrics/Gynecology at 865-305-9306.
A new trial will seek to improve bronchodilator
therapy in patients recovering from severe
exacerbations of chronic obstructive pulmonary
disease (COPD). This trial is conducted by
Rajiv Dhand, M.D., Department of Medicine.
Participants will compare nebulizers and drypowder inhalers to determine if one is superior
in improving lung function and drug deposition.
For information, contact Lauren Davis at
865-305-7975.

Why this matters:

Clinical trials and diagnostic investigations bring
treatments to patients more quickly.
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Students Among Us:

In Brief

Getting a Head Start on Medical Research
Medicine and chief of the
Division of Infectious Disease;
and Jonathan Wall, Ph.D.,
a professor and director of
Preclinical and Diagnostic
Molecular Imaging Laboratory.
Medical students also can
immerse in research. I. Reid
Collmann, M.D., former
dean of the Graduate School
of Medicine, dreamed of
UT student Brianna Rader, recent graduate of the Medical Explorations program, has
empowering medical students
conducted research in two programs at the UT Graduate School of Medicine, aided by her
with a passion for research
mentor, John Narro, M.D.
and an understanding of how
Through two unique programs at the UT
research affects patient care. Through his family’s
Graduate School of Medicine, students—our
generosity, the Collmann Medical Student
future doctors and researchers—get an early
Education Endowment gives future doctors time
exposure to medical careers and research. Each
in research labs, working alongside experienced
year, about 50 high school students participate
researchers at the Graduate School of Medicine.
in the Medical Explorations program, and each
Medical students and pre-medicine students can
summer, a handful of medical students shadow
participate in a variety of specialties during the
researchers at the Graduate School of Medicine
eight-week summer program.
to learn the value of medical research.
“By giving young people early opportunities,
“Completing the Medical Explorations
we are helping ensure good doctors in the
program and working with researchers solidified
future become good doctors who also conduct
my belief that successful doctors walk the line
research on behalf of their patients,” says Mitch
between the human side and the scientific side of
Goldman, M.D., the assistant dean for Research.
medicine,” says Brianna Rader, now a 20-yearFor more information about Medical
old student at the University of Tennessee,
Explorations, visit http://gsm.utmck.edu/
Knoxville, and 2009 graduate of Medical
medexp/main.cfm. For more information
Explorations.
about the Collmann Medical Student Education
Rader assisted Tom Terrell, M.D., an associate
Endowment, visit http://gsm.utmck.edu/
professor, Department of Family Medicine
students/assistantships.cfm.
Sports Medicine Program; John Narro, M.D.,
an associate professor in the Department of

Why this matters:

Faculty physicians and researchers at the
Graduate School of Medicine work every day to
support the education of future doctors, who will
shape healthcare in our community.
9
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Peptide Going Clinical, Transcontinental
The peptide is
turning heads in
Europe. Every day,
doctors in the U.S.
send their patients
with amyloid disease
to Great Britain, the
Netherlands and
Italy for an imaging
test not approved
for use stateside.
The European test
relies on a protein
Beating the competition. Using PET/CT imaging, Jonathan Wall, Ph.D., and his colleagues compared
that is isolated from
their p5 peptide imaging agent with an agent used in Europe, and the p5 agent imaged more
completely. Figures A and C demonstrate the performance of the p5 peptide, imaging more amyloid
human blood, so the
deposition than Figures B and D, which were imaged by the European agent.
U.S. Food and Drug
Technology developed by Jonathan Wall,
Administration will not approve its use. Wall’s
Ph.D., a professor and director of Preclinical
peptide, however, is synthesized, so he and his
and Diagnostic Molecular Imaging Laboratory,
team believe the p5 peptide imaged with PET/
and team members, Stephen Kennel, Emily
CT is the combination that will bring this lifeMartin, Tina Richey and Alan Stuckey, beats
changing test to America.
the competition and is poised to go clinical.
“Using the p5 peptide and PET/CT
Recently, Wall developed a new peptide imaging
technology, we compared our novel imaging
agent, a protein he calls p5. By using the
agent with the European agent and found
peptide in combination with positron emission
that p5 imaged amyloid in mice with chronic
tomography/computed tomography (PET/CT)
inflammation more completely,” Wall says.
imaging, the team has created a non-invasive
“This test also might be relevant for imaging
way to detect amyloid, a substance comprised
amyloid in patients with Type 2 diabetes,
of sticky protein fibers and sugar molecules that
rheumatoid arthritis and other diseases.”
is found in people with Alzheimer’s disease and
UT Graduate School of Medicine is
Type 2 diabetes. To further clinical trials using
collaborating with major U.S. medical facilities
the new peptide, Wall and his colleagues started
to begin a Phase I clinical trial, which will study
Solex LLC, a University of Tennessee start-up
the safety of imaging using the p5 peptide. Once
company, which received the right to license
funding has been realized, this trial could start
the intellectual property from the UT Research
within 18 months. For more information about
Foundation in 2012.
this research, call 865-305-5447.

Why this matters:

The success of the p5 peptide has the potential to
bring a critical imaging test to the U.S.
10
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Translating Research from Lab to Life:
Melanoma and ODAM
clinical observation made its
way back to Kestler, who began
investigating why ODAM
might be found in the main
tumor. Soon, this work will
circle back to the clinical setting,
where the ODAM finding
might be able to translate to
therapy for melanoma patients.
This translational research
already has resulted in
prognostic information. “I am
confident that when the primary
tumor is ODAM positive, the
chances are high that melanoma
has spread to the nodes,” Lewis
Daniel Kestler, Ph.D., and James Lewis, M.D., are taking research from clinical
observation to the lab and back to help patients with melanoma.
says. “This helps us help
patients make decisions.”
What do a basic science researcher and
Lewis is leading a prospective trial that seeks
a surgical oncologist have in common?
to determine the predictability of ODAM as it
Daniel Kestler, Ph.D., and James Lewis, M.D.,
relates to metastasis. He hopes his work will prove
are a perfect example of the best aspect of an
ODAM is upregulated (expressed) in melanomas
academic medical center: Translating research
that have spread. A molecular marker could lead
from lab to life. Kestler, the researcher, and
to a therapeutic target.
Lewis, the surgeon, collaborate on research that
The answer is by no means easy. “Genes do
is shedding light on melanoma and a seemingly
different
things in different pathways,” Kestler
unrelated protein called ODAM.
says. “We still have a lot of work to do at the
Melanoma is the deadliest form of skin cancer.
cellular level.”
ODAM (odontogenic ameloblast associated) is a
Kestler will attempt to determine ODAM’s
protein molecule originally found in dental tumors
role in tumor formation and regulation, and for
but more recently has also been found in melanoma.
patients with melanoma, he is working to answer
In a retrospective study, Lewis and his team
if ODAM in the lymph nodes acts as a
found that in 75% of cases, patients who had
protective agent.
sentinel nodes that were positive for melanoma
had ODAM in the main tumor. This significant

Why this matters:

Every 60 minutes, someone in the U.S. dies from
melanoma. Finding an indicator of metastasis
will improve accuracy of diagnosing and staging
the cancer and eventually could lead to more
targeted therapy.
11
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Research in Lung, Liver Diseases Funded
condition that may result in
serious lung disease in adults and
liver disease in infants, children
and adults. They hope to identify
and design small molecules that
can block the protein responsible
for AAT from forming clumps
therefore preventing its
malfunction. As a result of
this research, they will acquire
additional knowledge on clump
formation.
“Thanks to the Alpha-1
Foundation, we have the
opportunity to be the first
team to combine biochemical,
computational and neutron
science techniques,” says
Berthelier. “This leads us closer
to finding a cure.” The work will
be conducted in collaboration
with the University of Tennessee,
Knoxville, and the Spallation
Neutron Source/Oak Ridge
		
The work of Valerie Berthelier, Ph.D., received funding to continue research on
National Laboratory over a twoalpha1-antitrypsin, one of the most common hereditary disorders in the world.
year period.
Approximately 116 million people worldwide
Valerie Berthelier, Ph.D., an assistant professor
are carriers of AAT, and 1.1 million people have
and director of the Conformational Diseases
severe AAT, making it one of the most common
and Therapeutics Research Laboratory, received
and severe hereditary disorders in the world.
a research study grant totaling $200,000 from
The Alpha-1 Foundation is a nonprofit
the Alpha 1 Foundation. Findings from the
Florida corporation dedicated to providing
study, entitled, “Searching for Small Molecules as
the leadership and resources that will result in
Potent Inhibitors of Z-AAT,” could affect more
increased research, improved health, worldwide
than 1 million adults and children.
detection and a cure for Alpha-1 disease.
The goal of Berthelier and her research team
For more information, visit
is to find efficient treatments for the disease
www.alpha-1foundation.org
alpha1-antitrypsin deficiency (AAT), a hereditary

Why this matters:

Finding a cure for AAT could save the lives of 1
million people.
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Diagnostic Test Pioneered

News»

A multidisciplinary team at the Graduate School
of Medicine pioneered a novel diagnostic test for
May-Thurner Syndrome (MTS), also known as iliac
vein compression syndrome that is a compression of
the iliac vein in the left leg. Described in the July 25,
2012, issue of Annals of Vascular Surgery, T. Matthew
Jones, M.D., a fifth-year surgical resident, along with
others modified a diagnostic technique using duplex
ultrasonography by using a tourniquet-induced
venous engorgement. Typically, ultrasonography
does not thoroughly identify the obstruction,
but the modified test reveals iliocaval obstruction
characteristic of MTS.

Presentation Recognized
David Pickett, M.D., a resident in the Department
of Oral and Maxillofacial Surgery, received an
award for his poster presentation at the recent
annual meeting of the American Association of
Oral and Maxillofacial Surgeons. Pickett’s research
investigated effects of rhBMP-2 (a synthetic protein
to generate bone growth) treated with high doses of
bisphosphonates, drugs often used to slow bone loss
particularly for osteoporosis.

Physicians Learn from
Opiate-Addicted Babies
Craig Towers, M.D., an
associate professor in the
Department of Obstetrics/
Gynecology, and colleagues have
completed a short-term phase of
research studying babies who are
born with opiate addictions. For
more than two years, the team
Craig Towers, M.D.
examined the head circumferences
and femur lengths of their small patients. They
found that often babies born to mothers who abused
strong narcotics, including roxycodone, oxycodone
and Opana, while pregnant have smaller heads and
longer femurs. Towers will present these findings at

an upcoming meeting of the Society for MaternalFetal Medicine. A long-term study now is under way
to determine if the newborns’ physical deformities at
birth correlate with slow bone growth or cognitive
and neurological delays as the children grow.

Medical Librarians Present Findings
At the Medical Library Association meeting in
October 2012, medical librarians from Preston
Medical Library presented results of four research
projects. One project compared the impact of a
consumer and health information service on patienthealthcare provider interactions over a 10-year period
and was presented by Sandy Oelschlegel, M.L.I.S.,
the director of Preston Medical Library, and others.
Also presented by Oelschlegel was a survey of
regional medical campus libraries in the southeast.
Presented by Elizabeth Hinton, M.S.I.S., was a report
describing building an informatics tool to facilitate
analysis of a biomedical literature search, and J.
Michael Lindsay, M.S.I.S., discussed the library’s use
and survey of mobile apps to connect with physicians
and health consumers.

ECGs in Developing Countries
Dale Wortham, M.D., a professor in the
Department of Medicine, Division of Cardiology, and
director of the Cardiac Catheterization Laboratories,
and Xiaopeng Zhao, Ph.D., an assistant professor
in the UT College of Engineering, Mechanical,
Aerospace and Biomedical Engineering, recently
collaborated with others on a means to improve the
quality of care for patients in developing countries.
They developed a computer algorithm to evaluate
the quality of electrocardiograms (ECGs) collected
using mobile phones. The computer algorithms
examine noise and other interference to determine
if the ECG signals are reliable in helping physicians
make accurate diagnoses. This work has been lauded
by the national Physionet/Computing in Cardiology
Challenge and was published in Physiological
Measurement.

Your Chance to Advance
The people at the UT Graduate School of Medicine would be happy to discuss
our research programs and how your support can help advance healthcare. For
information about philanthropic giving to the UT Graduate School of Medicine
Office of Research, please contact the development office at 865-305-6611 or
development@utmck.edu.
If you would like more information about any of the research programs described in
this issue of Advance, please contact the UT Graduate School of Medicine at 865-3059290 or visit us online: http://gsm.utmck.edu/research/main.cfm.
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